Notably, TGF-β treatment in glioma cells significantly increases the expression of lncRNA UCA1; knockdown of UCA1 decreases Slug expression by releasing the inhibitory activity of miR-1 and miR-203, which are competitively bound by this lncRNA [113]. This evidence concerns the gene SNAI2 and central nervous system cancer.